Therapeutic Asset Ratings
761 results matching 1 filter
128,540 assets · 8,669 sponsors · 3,127 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
[68ga]ga-nota-t4
lung cancer
RenJi Hospital
P2/3
CCC
(50)
[177lu]ludotadipep
metastatic prostate carcinoma
FutureChem
P1/2
CCC
(49)
177lu-psma
metastatic prostate carcinoma
Peter MacCallum Cancer Centre, Australia
P2
CCC
(48)
[18f]rccb6
neoplasm
RenJi Hospital
P2
CCC
(48)
[68ga]ga-nota-r8b4
follicular lymphoma
RenJi Hospital
P2
CCC
(48)
[68ga]ga-nota-r8b4
lymphoma
RenJi Hospital
P2
CCC
(48)
[68ga]ga-nota-r8b4
mantle cell lymphoma
RenJi Hospital
P2
CCC
(48)
[68ga]ga-nota-rd06
follicular lymphoma
RenJi Hospital
P2
CCC
(48)
[68ga]ga-nota-rd06
lymphoma
RenJi Hospital
P2
CCC
(48)
[68ga]ga-nota-rd06
mantle cell lymphoma
RenJi Hospital
P2
CCC
(48)
Fpi-2265
metastatic prostate carcinoma
Fusion Pharmaceuticals Inc.
P2
CCC
(48)
Radium Dichloride
prostate cancer
Memorial Sloan Kettering Cancer Center
P2
CCC
(48)
[111in]-fpi-1967
FGFR3
Fusion Pharmaceuticals Inc.
P1/2
CCC
(48)
[111in]-fpi-1967
FGFR3 Overexpression
Fusion Pharmaceuticals Inc.
P1/2
CCC
(48)
[111in]-fpi-1967
FGFR3 Protein Overexpression
Fusion Pharmaceuticals Inc.
P1/2
CCC
(48)
[111in]-fpi-1967
FGFR3 Receptor
Fusion Pharmaceuticals Inc.
P1/2
CCC
(48)
[111in]-fpi-1967
Susceptible FGFR3 Genetic Alterations
Fusion Pharmaceuticals Inc.
P1/2
CCC
(48)
161Tb-NYM032
castration-resistant prostate carcinoma
Zhengguo Chen
P1/2
CCC
(48)
177lu-betabart
esophageal squamous cell carcinoma
Radiopharm Theranostics, Ltd
P1/2
CCC
(48)
177lu-betabart
head and neck squamous cell carcinoma
Radiopharm Theranostics, Ltd
P1/2
CCC
(48)
177lu-betabart
small cell lung carcinoma
Radiopharm Theranostics, Ltd
P1/2
CCC
(48)
[177lu]lu-dpi-4452
nonpapillary renal cell carcinoma
ITM Oncologics GmbH
P1/2
CCC
(48)
[177lu]lu-dpi-4452
head and neck cancer
ITM Oncologics GmbH
P1/2
CCC
(48)
[177lu]lu-dpi-4452
kidney neoplasm
ITM Oncologics GmbH
P1/2
CCC
(48)
[177lu]lu-dpi-4452
infiltrating bladder urothelial carcinoma
ITM Oncologics GmbH
P1/2
CCC
(48)
Showing 126 to 150 of 761 assets
Previous
Page 6 of 31
Next